Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone for CPAP Adherence in OSA
NCT05951023Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Eszopiclone with Placebo (2 arms). Primary endpoint: Mean use per night of continuous positive airway pressure (CPAP). Started Aug 2023; status: completed.
02
Drugs
eszopiclone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05951023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05951023.